Ads
related to: naepp asthma last update date calendar print
Search results
Results From The WOW.Com Content Network
By 2016 it had advanced to phase III [4] clinical trials for the treatment of asthma. [5] However, in 2019 Novartis announced that it was removing fevipiprant from its development program, given that the medicine has failed in two clinical trials in patients with moderate-to-severe asthma.
In 2001–2002, 11.4% of patients diagnosed with asthma and seen at an outpatient visit were prescribed oral corticosteroids as a long-term control therapy. [14] The National Asthma Education and Prevention Program (NAEPP) indicates systemic methylprednisolone in both short and long-term therapies to quickly control and to suppress persistent ...
The American Academy of Allergy, Asthma, and Immunology (AAAAI) dates back to the 1920s through the founding of two professional organizations: The Society for the Study of Asthma and Allied Conditions and the American Association for the Study of Allergy. [5] In 1943, the two organizations united to create the American Academy of Allergy (AAA).
The American College of Allergy, Asthma and Immunology (ACAAI) is an American professional association of immunologists, asthma specialists and allergists. The organization is headquartered in Arlington Heights, Illinois, United States of America. [1]
The Asthma and Allergy Foundation of America (AAFA) is the leading patient organization for people with asthma and allergies and the oldest asthma and allergy patient group in the world. AAFA is dedicated to saving lives and reducing the burden of disease for people with asthma, allergies, and related conditions through research, education ...
GINA conducts continuous review of scientific publications on asthma and is a leader in disseminating information about the care of patients with asthma. [2] GINA publishes resources such as evidence-based guidelines for asthma management, and runs special events such as World Asthma Day. GINA's guidelines, revised each year, are used by ...
EXHALE-4: [7] a global Phase III clinical trial to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma, is currently recruiting people ≥12 years old with a documented physician diagnosis of asthma who require treatment with at least low-dose inhaled corticosteroids and one other ...
The Annals of Allergy, Asthma, & Immunology is a monthly peer-reviewed medical journal covering allergy, asthma, and immunology. The journal was established in 1943 under the name Annals of Allergy , obtaining its current name in 1995.